Yale-New Haven Medical Center Infectious Disease

Topics

• HIV/AIDS Research and Interventions 570
• Vector-borne infectious diseases 466
• Macrophage Migration Inhibitory Factor 401
• HIV Research and Treatment 293
• Antifungal resistance and susceptibility 264
• Mosquito-borne diseases and control 264
• HIV-related health complications and treatments 256
• HIV, Drug Use, Sexual Risk 227
• Malaria Research and Control 225
• Leptospirosis research and findings 211
• Tuberculosis Research and Epidemiology 177
• Opioid Use Disorder Treatment 149

Most cited

1. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

   The New England journal of medicine · 2021 · 1,404 citations · Thomas Patterson

2. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.

   The New England journal of medicine · 2025 · 227 citations · Onyema Ogbuagu

3. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

   JAMA · 2025 · 210 citations · Sandra Springer

4. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.

   JAMA · 2023 · 462 citations · Sandra Springer

5. Distinguishing features of long COVID identified through immune profiling.

   Nature · 2023 · 599 citations · Inci Yildirim

6. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.

   The lancet. HIV · 2023 · 440 citations · Amy Justice